Human memory CTL response specific for influenza A virus is broad and multispecific

被引:148
|
作者
Gianfrani, C [1 ]
Oseroff, C [1 ]
Sidney, J [1 ]
Chesnut, RW [1 ]
Sette, A [1 ]
机构
[1] Epimmune Inc, Dept Immunol, San Diego, CA 92121 USA
关键词
HLA binding; immunodominance; CTL; viral infection; vaccines;
D O I
10.1016/S0198-8859(00)00105-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Class I restricted cytotoxic T-lymphocyte (CTL) responses are thought to be focused against few immunodominant epitopes. In humans, an often quoted example of such narrow focus is the influenza A (FLU) matrix 58-66 specific memory CTL activity, detectable in HLA-AZ individuals as a result of natural infection. Herein, we analyzed the repertoire of memory, FLU-specific CTLs in A2 and A11 positive individuals. Eighteen A2.1 binding peptides, derived from the FLU-Puerto Rico/8/34 (PR8) isolate, elicited CTL activity in A2.1/Kb transgenic mice upon direct immunization. These peptides were also tested for their capacity to recall memory CTL responses From peripheral blood mononuclear cells (PBMC) of human A2.1 donors. Besides the known dominant M1.58 peptide, 5 new epitopes (PA.46, PA.225, PB1.413, NA.75 and M1.59) were identified. Similarly, eleven, All-binding, FLU-PR8 peptides, which were immunogenic in HLA-A11/Kb transgenic mice, were assayed fur induction of recall CTL responses using peripheral blood lymphocytes from a cohort of All-positive donors. Fight different peptides (NP.188, NP.342, HA.63 HA.149 HA.450, M1.13, M1.178, and M2.70) induced memory CTL activity. Several of these peptides were found to be highly conserved amongst: different FLU isolates, and also capable of binding multiple A3 and A11 supertype molecules. Finally, 37 HLA-B7 binding peptides were also identified. In conclusion, a previously unappreciated breadth of FLU-specific, memory CTL responses in humans was revealed. The relevance of these findings to the design of multiepitope vaccines is discussed. Human Immunology 61, 438-452 (2000). (C) American Society for Histocompatibility and Immunogenetics, 2000. Published by Elsevier Science Inc.
引用
收藏
页码:438 / 452
页数:15
相关论文
共 50 条
  • [1] Preferential HLA usage in the influenza virus-specific CTL response
    Boon, ACM
    de Mutsert, G
    Fouchier, RAM
    Sintnicolaas, K
    Osterhaus, ADME
    Rimmelzwaan, GF
    JOURNAL OF IMMUNOLOGY, 2004, 172 (07): : 4435 - 4443
  • [2] Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL
    Jenkins, Misty R.
    Kedzierska, Katherine
    Doherty, Peter C.
    Turner, Stephen J.
    JOURNAL OF IMMUNOLOGY, 2007, 179 (01): : 64 - 70
  • [3] RECOGNITION OF INFLUENZA VIRUS-INFECTED B-CELL LINES BY HUMAN INFLUENZA VIRUS-SPECIFIC CTL
    ROTTEVEEL, FTM
    BRAAKMAN, E
    ROBBE, B
    LUCAS, CJ
    CELLULAR IMMUNOLOGY, 1988, 111 (02) : 473 - 481
  • [4] Recognition of influenza virus epitope variants by human CTL
    Rimmelzwaan, GF
    Boon, ACM
    de Mutsert, G
    Fouchier, RAM
    van Baarle, D
    Smith, DJ
    Lapedes, AS
    Sintnicolaas, K
    Osterhaus, ADME
    OPTIONS FOR THE CONTROL OF INFLUENZA V, 2004, 1263 : 145 - 148
  • [5] The anatomy of a protective CTL response in influenza virus infected lungs
    Cauley, Linda
    Wu, Tao
    Hu, Yinghong
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [6] Broad dispersion and lung localization of virus-specific memory B cells induced by influenza pneumonia
    Joo, Hye Mee
    He, Yuxia
    Sangster, Mark Y.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (09) : 3485 - 3490
  • [7] Human memory CD8+CTL response to Dengue
    Mathew, A
    Rothman, A
    Kurane, I
    Ennis, FA
    FASEB JOURNAL, 1996, 10 (06): : 1834 - 1834
  • [8] Augmentation of human influenza A virus-specific cytotoxic T lymphocyte memory by influenza vaccine and adjuvanted carriers (ISCOMS)
    Ennis, FA
    Cruz, J
    Jameson, J
    Klein, M
    Burt, D
    Thipphawong, J
    VIROLOGY, 1999, 259 (02) : 256 - 261
  • [9] Editorial response: Influenza, influenza virus vaccine, and human immunodeficiency virus infection
    Couch, RB
    CLINICAL INFECTIOUS DISEASES, 1999, 28 (03) : 548 - 551
  • [10] INHIBITION OF IFN-GAMMA WITH PREDNISOLONE PREVENTS THE GENERATION OF IN-VITRO HUMAN INFLUENZA-VIRUS SPECIFIC CTL ACTIVITY
    MBAWUIKE, IN
    LANGE, AR
    PHAMNGUYEN, K
    ACUNA, C
    CABALLERO, D
    FASEB JOURNAL, 1994, 8 (04): : A483 - A483